C12N 2840/107
Inhibiting translational read-through
Official title: inhibiting translational read-through
C12N2840/107 (Inhibiting translational read-through) appears on 9 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 11
- Assignees
- 10
- Inventors
- 29
- Latest grant
- 18 Aug 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Vectors and methods for targeted integration in loci comprising constitutively expressed genes18 Aug 2020US 10,745,717 B2Murdoch Childrens Research Institute
- Furin-knockdown bi-functional RNA4 Jul 2017US 9,695,422 B2Gradalis, Inc.
- Furin-knockdown bi-functional RNA13 Oct 2015US 9,157,084 B2Gradalis, Inc.
- Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes13 Dec 2011US 8,076,100 B2The United States of America as represented by the Department of Health and Human Services
- DNA expression vectors and methods of use14 Sep 2010US 7,795,017 B2Emory University
- Methods and compositions using an engineered release factor16 May 2024US 2024/0158735 A1Opentrons Labworks Inc.
- Vectors and methods for targeted integration in loci comprising constitutively expressed genes1 Mar 2018US 2018/0057842 A1Murdoch Childrens Research Institute
- Furin-knockdown bi-functional rna24 Dec 2015US 2015/0368651 A1Gradalis, Inc.
- Furin-knockdown bi-functional rna23 Jun 2011US 2011/0150832 A1Gradalis, Inc.
- Compositions and methods for generating an immune response1 Mar 2007US 2007/0048861 A1
Most cited
By later US patents
- Fibrinolytic and anti-thrombotic cleavable dimers27US 5,434,073 ABritish Bio-Technology Limited · 1995
- Activatable fibrinolytic and anti-thrombotic proteins10US 5,637,492 ABritish Biotech Pharmaceuticals Limited · 1997
- DNA expression vectors and methods of use10US 7,795,017 B2Emory University · 2010
- Furin-knockdown bi-functional RNA5US 9,157,084 B2Gradalis, Inc. · 2015
- Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes3US 6,656,706 B2The United States of America as represented by the Department of Health and Human Services · 2003